In this week’s blog, IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie provides mid-year updates on exciting developments in ...
The fact a species’ cancer risk doesn’t increase with its size is called Peto’s paradox, after Professor Sir Richard Peto, one of our researchers, who ...
Learn about myeloma, a complex form of cancer, and discover how to provide crucial care and support as a care partner or caregiver. In this informative ...
The Food and Drug Administration (FDA) approved Akeega (niraparib and abiraterone acetate) with prednisone for the treatment of adults with deleterious or ...
A clinical trial will investigate a new subcutaneous drug for the treatment of certain patients with B-cell non-Hodgkin lymphoma. The first patient received ...
Lung cancer is the second most common cancer in the country, accounting for about 1 in every 5 cancer related deaths, according to the American Cancer ...
TODAY show contributor, Jill Martin, provided an update on her breast cancer.Jill Martin, commonly known for being a contributor the TODAY show, said that ...
Opdivo is a common treatment for patients with kidney cancer, though the drug can come with immune-related side effects.The use of corticosteroids during ...